In addition, inhibition of PFKFB3 has been reported to disrupt pathological angiogenesis and induce normalization of tumor vasculature, thereby reducing metastasis and improving chemotherapy efficacy [16]. This evidence concerns the gene PFKFB3 and neoplasm.